C-Myc inhibitor 9
C-Myc inhibitor 9 (compound 332) is a c-Myc inhibitor with an logEC50 of ≥6. c-Myc inhibitor 9 inhibits tumor growth in nude mouse models. c-Myc inhibitor 9 can be used for cancer research[1].
Product Specifications
CAS Number
[2799717-96-5]
UNSPSC
12352005
Target
C-Myc
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/c-myc-inhibitor-9.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=C2C(SC3=NC(C4=CC=C(C5(CC5)N)C=C4)=CN32)=C1)NCCCN6CCCCC6
Molecular Formula
C27H31N5OS
Molecular Weight
473.63
References & Citations
[1]Sheppard, David William, et al. Preparation of heteroaryl compounds as c-MYC mRNA translation modulators and uses thereof in the treatment of cancer. WO2022150316. 2022.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6235979-01 0.1 mL
UBE2D4 (Ubiquitin-conjugating Enzyme E2 D4, HBUCE1, UBCH5D, Ubiquitin Carrier Protein D4, Ubiquitin-protein Ligase D4) (MaxLight 750)
Sign In for Pricing
View Details 
MBS6235979-02 5x 0.1 mL
UBE2D4 (Ubiquitin-conjugating Enzyme E2 D4, HBUCE1, UBCH5D, Ubiquitin Carrier Protein D4, Ubiquitin-protein Ligase D4) (MaxLight 750)
Sign In for Pricing
View Details 